A risk signature constructed by Tregs-related genes predict the clinical outcomes and immune therapeutic response in kidney cancer
Abstract Regulatory T cells (Tregs) have been found to be related to immune therapeutic resistance in kidney cancer. However, the potential Tregs-related genes still need to be explored. Our study found that patients with high Tregs activity show poor prognosis. Through co-expression and differentia...
Saved in:
Main Authors: | Gang Li, Jingmin Cui, Tao Li, Wenhan Li, Peilin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-025-01787-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases
by: Yuming Lu, et al.
Published: (2025-01-01) -
T-regulatory cells for the treatment of autoimmune diseases
by: Marina S. Fisher, et al.
Published: (2025-02-01) -
Staphylococcus aureus-specific TIGIT+ Treg are present in the blood of healthy subjects – a hurdle for vaccination?
by: Jonah Clegg, et al.
Published: (2025-02-01) -
Periplanta americana extract regulates the Th17/Treg cell balance via Notch1 in ulcerative colitis
by: Yanqiu Zheng, et al.
Published: (2025-01-01) -
Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells
by: Na Tian, et al.
Published: (2025-01-01)